nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2C8—Paclitaxel—ovarian cancer	0.0764	0.249	CbGbCtD
Montelukast—CYP3A4—Topotecan—ovarian cancer	0.0626	0.204	CbGbCtD
Montelukast—CYP2C9—Paclitaxel—ovarian cancer	0.0533	0.174	CbGbCtD
Montelukast—CYP3A4—Vinorelbine—ovarian cancer	0.0441	0.144	CbGbCtD
Montelukast—CYP3A4—Paclitaxel—ovarian cancer	0.031	0.101	CbGbCtD
Montelukast—CYP3A4—Docetaxel—ovarian cancer	0.0224	0.0731	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—ovarian cancer	0.0167	0.0545	CbGbCtD
Montelukast—PTGS1—oviduct—ovarian cancer	0.00989	0.0804	CbGeAlD
Montelukast—CYSLTR1—uterus—ovarian cancer	0.00844	0.0686	CbGeAlD
Montelukast—CYSLTR1—female reproductive system—ovarian cancer	0.00759	0.0617	CbGeAlD
Montelukast—CYSLTR1—bone marrow—ovarian cancer	0.00716	0.0583	CbGeAlD
Montelukast—CYSLTR1—vagina—ovarian cancer	0.00686	0.0558	CbGeAlD
Montelukast—ALOX5—decidua—ovarian cancer	0.00584	0.0475	CbGeAlD
Montelukast—ALOX5—female reproductive system—ovarian cancer	0.0046	0.0374	CbGeAlD
Montelukast—SLCO2B1—decidua—ovarian cancer	0.0045	0.0366	CbGeAlD
Montelukast—CYSLTR1—lymph node—ovarian cancer	0.00444	0.0361	CbGeAlD
Montelukast—ALOX5—bone marrow—ovarian cancer	0.00434	0.0353	CbGeAlD
Montelukast—ALOX5—female gonad—ovarian cancer	0.00418	0.034	CbGeAlD
Montelukast—SLCO2B1—uterus—ovarian cancer	0.00394	0.032	CbGeAlD
Montelukast—ALOX5—testis—ovarian cancer	0.00371	0.0302	CbGeAlD
Montelukast—CYP2A6—vagina—ovarian cancer	0.00366	0.0298	CbGeAlD
Montelukast—SLCO2B1—female reproductive system—ovarian cancer	0.00354	0.0288	CbGeAlD
Montelukast—SLCO2B1—female gonad—ovarian cancer	0.00322	0.0262	CbGeAlD
Montelukast—SLCO2B1—testis—ovarian cancer	0.00285	0.0232	CbGeAlD
Montelukast—CYP2C8—endometrium—ovarian cancer	0.00275	0.0223	CbGeAlD
Montelukast—ALOX5—lymph node—ovarian cancer	0.00269	0.0219	CbGeAlD
Montelukast—PTGS1—epithelium—ovarian cancer	0.00248	0.0202	CbGeAlD
Montelukast—PTGS1—uterine cervix—ovarian cancer	0.00246	0.02	CbGeAlD
Montelukast—CYP2C8—female reproductive system—ovarian cancer	0.00227	0.0185	CbGeAlD
Montelukast—PTGS1—endometrium—ovarian cancer	0.00223	0.0181	CbGeAlD
Montelukast—SLCO2B1—lymph node—ovarian cancer	0.00207	0.0168	CbGeAlD
Montelukast—CYP2C8—vagina—ovarian cancer	0.00206	0.0167	CbGeAlD
Montelukast—PTGS1—uterus—ovarian cancer	0.00205	0.0167	CbGeAlD
Montelukast—CYP2C9—female reproductive system—ovarian cancer	0.00202	0.0164	CbGeAlD
Montelukast—PTGS1—female reproductive system—ovarian cancer	0.00184	0.015	CbGeAlD
Montelukast—CYP2C8—testis—ovarian cancer	0.00184	0.0149	CbGeAlD
Montelukast—PTGS1—female gonad—ovarian cancer	0.00168	0.0136	CbGeAlD
Montelukast—PTGS1—vagina—ovarian cancer	0.00167	0.0136	CbGeAlD
Montelukast—CYP3A4—female reproductive system—ovarian cancer	0.00154	0.0125	CbGeAlD
Montelukast—PTGS1—testis—ovarian cancer	0.00149	0.0121	CbGeAlD
Montelukast—PTGS1—lymph node—ovarian cancer	0.00108	0.00877	CbGeAlD
Montelukast—Hepatitis—Docetaxel—ovarian cancer	0.001	0.00176	CcSEcCtD
Montelukast—Diarrhoea—Topotecan—ovarian cancer	0.001	0.00175	CcSEcCtD
Montelukast—Hypoaesthesia—Docetaxel—ovarian cancer	0.001	0.00175	CcSEcCtD
Montelukast—Pharyngitis—Docetaxel—ovarian cancer	0.000997	0.00175	CcSEcCtD
Montelukast—Urticaria—Vinorelbine—ovarian cancer	0.000995	0.00174	CcSEcCtD
Montelukast—Urinary tract disorder—Docetaxel—ovarian cancer	0.000992	0.00174	CcSEcCtD
Montelukast—Muscle spasms—Paclitaxel—ovarian cancer	0.000992	0.00174	CcSEcCtD
Montelukast—Abdominal pain—Vinorelbine—ovarian cancer	0.00099	0.00173	CcSEcCtD
Montelukast—Body temperature increased—Vinorelbine—ovarian cancer	0.00099	0.00173	CcSEcCtD
Montelukast—Connective tissue disorder—Docetaxel—ovarian cancer	0.000987	0.00173	CcSEcCtD
Montelukast—Urethral disorder—Docetaxel—ovarian cancer	0.000985	0.00173	CcSEcCtD
Montelukast—Diarrhoea—Melphalan—ovarian cancer	0.000981	0.00172	CcSEcCtD
Montelukast—Nausea—Chlorambucil—ovarian cancer	0.000977	0.00171	CcSEcCtD
Montelukast—Dizziness—Topotecan—ovarian cancer	0.000968	0.0017	CcSEcCtD
Montelukast—Tremor—Paclitaxel—ovarian cancer	0.000967	0.00169	CcSEcCtD
Montelukast—Erythema multiforme—Docetaxel—ovarian cancer	0.00095	0.00166	CcSEcCtD
Montelukast—Agitation—Paclitaxel—ovarian cancer	0.000948	0.00166	CcSEcCtD
Montelukast—Angioedema—Paclitaxel—ovarian cancer	0.000943	0.00165	CcSEcCtD
Montelukast—Cardiac disorder—Docetaxel—ovarian cancer	0.000933	0.00163	CcSEcCtD
Montelukast—Vomiting—Topotecan—ovarian cancer	0.000931	0.00163	CcSEcCtD
Montelukast—Rash—Topotecan—ovarian cancer	0.000923	0.00162	CcSEcCtD
Montelukast—Hypersensitivity—Vinorelbine—ovarian cancer	0.000923	0.00162	CcSEcCtD
Montelukast—Dermatitis—Topotecan—ovarian cancer	0.000922	0.00162	CcSEcCtD
Montelukast—Headache—Topotecan—ovarian cancer	0.000917	0.00161	CcSEcCtD
Montelukast—Palpitations—Paclitaxel—ovarian cancer	0.000912	0.0016	CcSEcCtD
Montelukast—Vomiting—Melphalan—ovarian cancer	0.000911	0.0016	CcSEcCtD
Montelukast—Immune system disorder—Docetaxel—ovarian cancer	0.000908	0.00159	CcSEcCtD
Montelukast—Mediastinal disorder—Docetaxel—ovarian cancer	0.000906	0.00159	CcSEcCtD
Montelukast—Rash—Melphalan—ovarian cancer	0.000904	0.00158	CcSEcCtD
Montelukast—Dermatitis—Melphalan—ovarian cancer	0.000903	0.00158	CcSEcCtD
Montelukast—Cough—Paclitaxel—ovarian cancer	0.000901	0.00158	CcSEcCtD
Montelukast—Asthenia—Vinorelbine—ovarian cancer	0.000898	0.00157	CcSEcCtD
Montelukast—Convulsion—Paclitaxel—ovarian cancer	0.000894	0.00157	CcSEcCtD
Montelukast—Pruritus—Vinorelbine—ovarian cancer	0.000886	0.00155	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000882	0.00155	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000882	0.00155	CcSEcCtD
Montelukast—Mental disorder—Docetaxel—ovarian cancer	0.00088	0.00154	CcSEcCtD
Montelukast—Arthralgia—Paclitaxel—ovarian cancer	0.000879	0.00154	CcSEcCtD
Montelukast—Myalgia—Paclitaxel—ovarian cancer	0.000879	0.00154	CcSEcCtD
Montelukast—Nasopharyngitis—Epirubicin—ovarian cancer	0.000876	0.00153	CcSEcCtD
Montelukast—Anxiety—Paclitaxel—ovarian cancer	0.000876	0.00153	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000873	0.00153	CcSEcCtD
Montelukast—Nausea—Topotecan—ovarian cancer	0.000869	0.00152	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000864	0.00151	CcSEcCtD
Montelukast—Diarrhoea—Vinorelbine—ovarian cancer	0.000857	0.0015	CcSEcCtD
Montelukast—Nausea—Melphalan—ovarian cancer	0.000851	0.00149	CcSEcCtD
Montelukast—Asthma—Epirubicin—ovarian cancer	0.000847	0.00148	CcSEcCtD
Montelukast—Influenza—Epirubicin—ovarian cancer	0.000847	0.00148	CcSEcCtD
Montelukast—Oedema—Paclitaxel—ovarian cancer	0.000842	0.00148	CcSEcCtD
Montelukast—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000842	0.00148	CcSEcCtD
Montelukast—Muscle spasms—Docetaxel—ovarian cancer	0.000841	0.00147	CcSEcCtD
Montelukast—Eosinophilia—Epirubicin—ovarian cancer	0.000838	0.00147	CcSEcCtD
Montelukast—Infection—Paclitaxel—ovarian cancer	0.000837	0.00147	CcSEcCtD
Montelukast—Pancreatitis—Epirubicin—ovarian cancer	0.00083	0.00145	CcSEcCtD
Montelukast—Dizziness—Vinorelbine—ovarian cancer	0.000828	0.00145	CcSEcCtD
Montelukast—Nervous system disorder—Paclitaxel—ovarian cancer	0.000826	0.00145	CcSEcCtD
Montelukast—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000825	0.00144	CcSEcCtD
Montelukast—Skin disorder—Paclitaxel—ovarian cancer	0.000818	0.00143	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000816	0.00143	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000816	0.00143	CcSEcCtD
Montelukast—Bronchitis—Epirubicin—ovarian cancer	0.000814	0.00143	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000811	0.00142	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000799	0.0014	CcSEcCtD
Montelukast—Vomiting—Vinorelbine—ovarian cancer	0.000796	0.00139	CcSEcCtD
Montelukast—Rash—Vinorelbine—ovarian cancer	0.00079	0.00138	CcSEcCtD
Montelukast—Dermatitis—Vinorelbine—ovarian cancer	0.000789	0.00138	CcSEcCtD
Montelukast—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000787	0.00138	CcSEcCtD
Montelukast—Headache—Vinorelbine—ovarian cancer	0.000784	0.00137	CcSEcCtD
Montelukast—Influenza—Doxorubicin—ovarian cancer	0.000783	0.00137	CcSEcCtD
Montelukast—Asthma—Doxorubicin—ovarian cancer	0.000783	0.00137	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—ovarian cancer	0.000776	0.00136	CcSEcCtD
Montelukast—Palpitations—Docetaxel—ovarian cancer	0.000773	0.00135	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—ovarian cancer	0.000768	0.00135	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000767	0.00134	CcSEcCtD
Montelukast—Cough—Docetaxel—ovarian cancer	0.000763	0.00134	CcSEcCtD
Montelukast—Insomnia—Paclitaxel—ovarian cancer	0.000762	0.00133	CcSEcCtD
Montelukast—Pneumonia—Epirubicin—ovarian cancer	0.000759	0.00133	CcSEcCtD
Montelukast—Convulsion—Docetaxel—ovarian cancer	0.000758	0.00133	CcSEcCtD
Montelukast—Paraesthesia—Paclitaxel—ovarian cancer	0.000756	0.00133	CcSEcCtD
Montelukast—Infestation—Epirubicin—ovarian cancer	0.000755	0.00132	CcSEcCtD
Montelukast—Infestation NOS—Epirubicin—ovarian cancer	0.000755	0.00132	CcSEcCtD
Montelukast—Drowsiness—Epirubicin—ovarian cancer	0.000755	0.00132	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—ovarian cancer	0.000753	0.00132	CcSEcCtD
Montelukast—Somnolence—Paclitaxel—ovarian cancer	0.000749	0.00131	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000748	0.00131	CcSEcCtD
Montelukast—Arthralgia—Docetaxel—ovarian cancer	0.000745	0.0013	CcSEcCtD
Montelukast—Myalgia—Docetaxel—ovarian cancer	0.000745	0.0013	CcSEcCtD
Montelukast—Nausea—Vinorelbine—ovarian cancer	0.000744	0.0013	CcSEcCtD
Montelukast—Dyspepsia—Paclitaxel—ovarian cancer	0.000741	0.0013	CcSEcCtD
Montelukast—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00074	0.0013	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00074	0.0013	CcSEcCtD
Montelukast—Jaundice—Epirubicin—ovarian cancer	0.000736	0.00129	CcSEcCtD
Montelukast—Conjunctivitis—Epirubicin—ovarian cancer	0.000734	0.00129	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000728	0.00128	CcSEcCtD
Montelukast—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000727	0.00127	CcSEcCtD
Montelukast—Fatigue—Paclitaxel—ovarian cancer	0.000726	0.00127	CcSEcCtD
Montelukast—Pain—Paclitaxel—ovarian cancer	0.00072	0.00126	CcSEcCtD
Montelukast—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000714	0.00125	CcSEcCtD
Montelukast—Anaphylactic shock—Docetaxel—ovarian cancer	0.000714	0.00125	CcSEcCtD
Montelukast—Oedema—Docetaxel—ovarian cancer	0.000714	0.00125	CcSEcCtD
Montelukast—Epistaxis—Epirubicin—ovarian cancer	0.000712	0.00125	CcSEcCtD
Montelukast—Infection—Docetaxel—ovarian cancer	0.000709	0.00124	CcSEcCtD
Montelukast—Sinusitis—Epirubicin—ovarian cancer	0.000708	0.00124	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—ovarian cancer	0.000703	0.00123	CcSEcCtD
Montelukast—Nervous system disorder—Docetaxel—ovarian cancer	0.0007	0.00123	CcSEcCtD
Montelukast—Thrombocytopenia—Docetaxel—ovarian cancer	0.000699	0.00122	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—ovarian cancer	0.000699	0.00122	CcSEcCtD
Montelukast—Infestation—Doxorubicin—ovarian cancer	0.000699	0.00122	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—ovarian cancer	0.000699	0.00122	CcSEcCtD
Montelukast—Skin disorder—Docetaxel—ovarian cancer	0.000693	0.00121	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000693	0.00121	CcSEcCtD
Montelukast—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000689	0.00121	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000685	0.0012	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—ovarian cancer	0.000681	0.00119	CcSEcCtD
Montelukast—Rhinitis—Epirubicin—ovarian cancer	0.000679	0.00119	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—ovarian cancer	0.000679	0.00119	CcSEcCtD
Montelukast—Hepatitis—Epirubicin—ovarian cancer	0.000678	0.00119	CcSEcCtD
Montelukast—Hypoaesthesia—Epirubicin—ovarian cancer	0.000674	0.00118	CcSEcCtD
Montelukast—Pharyngitis—Epirubicin—ovarian cancer	0.000673	0.00118	CcSEcCtD
Montelukast—Urinary tract disorder—Epirubicin—ovarian cancer	0.000669	0.00117	CcSEcCtD
Montelukast—Urticaria—Paclitaxel—ovarian cancer	0.000669	0.00117	CcSEcCtD
Montelukast—Connective tissue disorder—Epirubicin—ovarian cancer	0.000666	0.00117	CcSEcCtD
Montelukast—Abdominal pain—Paclitaxel—ovarian cancer	0.000666	0.00117	CcSEcCtD
Montelukast—Body temperature increased—Paclitaxel—ovarian cancer	0.000666	0.00117	CcSEcCtD
Montelukast—Urethral disorder—Epirubicin—ovarian cancer	0.000664	0.00116	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000661	0.00116	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—ovarian cancer	0.000659	0.00115	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—ovarian cancer	0.000655	0.00115	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00065	0.00114	CcSEcCtD
Montelukast—Insomnia—Docetaxel—ovarian cancer	0.000646	0.00113	CcSEcCtD
Montelukast—Paraesthesia—Docetaxel—ovarian cancer	0.000641	0.00112	CcSEcCtD
Montelukast—Erythema multiforme—Epirubicin—ovarian cancer	0.000641	0.00112	CcSEcCtD
Montelukast—Somnolence—Docetaxel—ovarian cancer	0.000635	0.00111	CcSEcCtD
Montelukast—Cardiac disorder—Epirubicin—ovarian cancer	0.000629	0.0011	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—ovarian cancer	0.000629	0.0011	CcSEcCtD
Montelukast—Dyspepsia—Docetaxel—ovarian cancer	0.000628	0.0011	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—ovarian cancer	0.000627	0.0011	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000624	0.00109	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—ovarian cancer	0.000622	0.00109	CcSEcCtD
Montelukast—Hypersensitivity—Paclitaxel—ovarian cancer	0.000621	0.00109	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000619	0.00109	CcSEcCtD
Montelukast—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000616	0.00108	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000616	0.00108	CcSEcCtD
Montelukast—Fatigue—Docetaxel—ovarian cancer	0.000615	0.00108	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—ovarian cancer	0.000615	0.00108	CcSEcCtD
Montelukast—Immune system disorder—Epirubicin—ovarian cancer	0.000612	0.00107	CcSEcCtD
Montelukast—Mediastinal disorder—Epirubicin—ovarian cancer	0.000611	0.00107	CcSEcCtD
Montelukast—Pain—Docetaxel—ovarian cancer	0.00061	0.00107	CcSEcCtD
Montelukast—Asthenia—Paclitaxel—ovarian cancer	0.000604	0.00106	CcSEcCtD
Montelukast—Pruritus—Paclitaxel—ovarian cancer	0.000596	0.00104	CcSEcCtD
Montelukast—Mental disorder—Epirubicin—ovarian cancer	0.000594	0.00104	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—ovarian cancer	0.000593	0.00104	CcSEcCtD
Montelukast—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000584	0.00102	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—ovarian cancer	0.000582	0.00102	CcSEcCtD
Montelukast—Diarrhoea—Paclitaxel—ovarian cancer	0.000576	0.00101	CcSEcCtD
Montelukast—Muscle spasms—Epirubicin—ovarian cancer	0.000567	0.000994	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—ovarian cancer	0.000566	0.000992	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000565	0.00099	CcSEcCtD
Montelukast—Abdominal pain—Docetaxel—ovarian cancer	0.000564	0.000989	CcSEcCtD
Montelukast—Body temperature increased—Docetaxel—ovarian cancer	0.000564	0.000989	CcSEcCtD
Montelukast—Dizziness—Paclitaxel—ovarian cancer	0.000557	0.000976	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—ovarian cancer	0.000549	0.000963	CcSEcCtD
Montelukast—Agitation—Epirubicin—ovarian cancer	0.000542	0.00095	CcSEcCtD
Montelukast—Vomiting—Paclitaxel—ovarian cancer	0.000536	0.000938	CcSEcCtD
Montelukast—Rash—Paclitaxel—ovarian cancer	0.000531	0.00093	CcSEcCtD
Montelukast—Dermatitis—Paclitaxel—ovarian cancer	0.000531	0.00093	CcSEcCtD
Montelukast—Headache—Paclitaxel—ovarian cancer	0.000528	0.000924	CcSEcCtD
Montelukast—Hypersensitivity—Docetaxel—ovarian cancer	0.000526	0.000921	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—ovarian cancer	0.000525	0.00092	CcSEcCtD
Montelukast—Palpitations—Epirubicin—ovarian cancer	0.000521	0.000913	CcSEcCtD
Montelukast—Cough—Epirubicin—ovarian cancer	0.000515	0.000902	CcSEcCtD
Montelukast—Asthenia—Docetaxel—ovarian cancer	0.000512	0.000897	CcSEcCtD
Montelukast—Convulsion—Epirubicin—ovarian cancer	0.000511	0.000896	CcSEcCtD
Montelukast—Pruritus—Docetaxel—ovarian cancer	0.000505	0.000885	CcSEcCtD
Montelukast—Myalgia—Epirubicin—ovarian cancer	0.000502	0.00088	CcSEcCtD
Montelukast—Arthralgia—Epirubicin—ovarian cancer	0.000502	0.00088	CcSEcCtD
Montelukast—Agitation—Doxorubicin—ovarian cancer	0.000502	0.000879	CcSEcCtD
Montelukast—Anxiety—Epirubicin—ovarian cancer	0.000501	0.000877	CcSEcCtD
Montelukast—Nausea—Paclitaxel—ovarian cancer	0.0005	0.000876	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000499	0.000874	CcSEcCtD
Montelukast—Diarrhoea—Docetaxel—ovarian cancer	0.000488	0.000856	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—ovarian cancer	0.000482	0.000845	CcSEcCtD
Montelukast—Oedema—Epirubicin—ovarian cancer	0.000482	0.000844	CcSEcCtD
Montelukast—Anaphylactic shock—Epirubicin—ovarian cancer	0.000482	0.000844	CcSEcCtD
Montelukast—Infection—Epirubicin—ovarian cancer	0.000478	0.000838	CcSEcCtD
Montelukast—Cough—Doxorubicin—ovarian cancer	0.000476	0.000835	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—ovarian cancer	0.000473	0.000829	CcSEcCtD
Montelukast—Nervous system disorder—Epirubicin—ovarian cancer	0.000472	0.000827	CcSEcCtD
Montelukast—Dizziness—Docetaxel—ovarian cancer	0.000472	0.000827	CcSEcCtD
Montelukast—Thrombocytopenia—Epirubicin—ovarian cancer	0.000471	0.000826	CcSEcCtD
Montelukast—Skin disorder—Epirubicin—ovarian cancer	0.000468	0.000819	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—ovarian cancer	0.000465	0.000814	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—ovarian cancer	0.000465	0.000814	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—ovarian cancer	0.000463	0.000811	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000462	0.000809	CcSEcCtD
Montelukast—Vomiting—Docetaxel—ovarian cancer	0.000454	0.000795	CcSEcCtD
Montelukast—Rash—Docetaxel—ovarian cancer	0.00045	0.000789	CcSEcCtD
Montelukast—Dermatitis—Docetaxel—ovarian cancer	0.00045	0.000788	CcSEcCtD
Montelukast—Headache—Docetaxel—ovarian cancer	0.000447	0.000784	CcSEcCtD
Montelukast—Oedema—Doxorubicin—ovarian cancer	0.000446	0.000781	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000446	0.000781	CcSEcCtD
Montelukast—Infection—Doxorubicin—ovarian cancer	0.000443	0.000775	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000439	0.000769	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—ovarian cancer	0.000437	0.000765	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000436	0.000764	CcSEcCtD
Montelukast—Insomnia—Epirubicin—ovarian cancer	0.000436	0.000763	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—ovarian cancer	0.000433	0.000758	CcSEcCtD
Montelukast—Paraesthesia—Epirubicin—ovarian cancer	0.000432	0.000758	CcSEcCtD
Montelukast—Somnolence—Epirubicin—ovarian cancer	0.000428	0.00075	CcSEcCtD
Montelukast—Nausea—Docetaxel—ovarian cancer	0.000424	0.000743	CcSEcCtD
Montelukast—Dyspepsia—Epirubicin—ovarian cancer	0.000424	0.000743	CcSEcCtD
Montelukast—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000416	0.000728	CcSEcCtD
Montelukast—Fatigue—Epirubicin—ovarian cancer	0.000415	0.000727	CcSEcCtD
Montelukast—Pain—Epirubicin—ovarian cancer	0.000412	0.000721	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000406	0.000711	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—ovarian cancer	0.000403	0.000706	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—ovarian cancer	0.0004	0.000701	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—ovarian cancer	0.000396	0.000694	CcSEcCtD
Montelukast—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000394	0.00069	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—ovarian cancer	0.000392	0.000687	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000385	0.000674	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—ovarian cancer	0.000384	0.000673	CcSEcCtD
Montelukast—Urticaria—Epirubicin—ovarian cancer	0.000383	0.00067	CcSEcCtD
Montelukast—Pain—Doxorubicin—ovarian cancer	0.000381	0.000668	CcSEcCtD
Montelukast—Abdominal pain—Epirubicin—ovarian cancer	0.000381	0.000667	CcSEcCtD
Montelukast—Body temperature increased—Epirubicin—ovarian cancer	0.000381	0.000667	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000364	0.000638	CcSEcCtD
Montelukast—Hypersensitivity—Epirubicin—ovarian cancer	0.000355	0.000622	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—ovarian cancer	0.000354	0.00062	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—ovarian cancer	0.000352	0.000617	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—ovarian cancer	0.000352	0.000617	CcSEcCtD
Montelukast—Asthenia—Epirubicin—ovarian cancer	0.000345	0.000605	CcSEcCtD
Montelukast—Pruritus—Epirubicin—ovarian cancer	0.000341	0.000597	CcSEcCtD
Montelukast—Diarrhoea—Epirubicin—ovarian cancer	0.000329	0.000577	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—ovarian cancer	0.000328	0.000575	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—ovarian cancer	0.00032	0.00056	CcSEcCtD
Montelukast—Dizziness—Epirubicin—ovarian cancer	0.000318	0.000558	CcSEcCtD
Montelukast—Pruritus—Doxorubicin—ovarian cancer	0.000315	0.000552	CcSEcCtD
Montelukast—Vomiting—Epirubicin—ovarian cancer	0.000306	0.000536	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—ovarian cancer	0.000305	0.000534	CcSEcCtD
Montelukast—Rash—Epirubicin—ovarian cancer	0.000304	0.000532	CcSEcCtD
Montelukast—Dermatitis—Epirubicin—ovarian cancer	0.000303	0.000531	CcSEcCtD
Montelukast—Headache—Epirubicin—ovarian cancer	0.000302	0.000528	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—ovarian cancer	0.000295	0.000516	CcSEcCtD
Montelukast—Nausea—Epirubicin—ovarian cancer	0.000286	0.000501	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—ovarian cancer	0.000283	0.000496	CcSEcCtD
Montelukast—Rash—Doxorubicin—ovarian cancer	0.000281	0.000492	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—ovarian cancer	0.000281	0.000492	CcSEcCtD
Montelukast—Headache—Doxorubicin—ovarian cancer	0.000279	0.000489	CcSEcCtD
Montelukast—Nausea—Doxorubicin—ovarian cancer	0.000265	0.000464	CcSEcCtD
